Treatment of gastrointestinal bleeding with idarucizumab in a patient receiving dabigatran.

CONCLUSION: A patient who had recently undergone PCI and DES placement and was receiving aspirin, clopidogrel, and dabigatran for atrial fibrillation was successfully treated for acute GI bleeding with idarucizumab without the use of a hemostatic agent.
PMID: 29343478 [PubMed - as supplied by publisher]

Source: American Journal of Health-System Pharmacy : AJHP - January 17, 2018 Category: Drugs & Pharmacology Authors: Mourafetis J, Doctor N, Leung S Tags: Am J Health Syst Pharm Source Type: research